A new grant from the Susan G. Komen Breast Cancer Foundation will allow a University of Tennessee professor to conduct a groundbreaking study into how best to treat well diagnosed depression in breast cancer patients.
Interim Results Presented at EASL from PROVE 1 Clinical Trial of Investigational Drug Telaprevir in Patients with Genotype 1 Hepatitis C. PROVE 1 data support potential to shorten treatment duration in treatment-na?ve, genotype 1 HCV patients.
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.
The World Health Organization (WHO) is expanding the global effort to eliminate Chagas, a parasitic disease which affects an estimated nine million people, mostly children.
A series of quietly exhaled breaths might indicate whether or not a patient is at risk for lung cancer, according to researchers from the New York State Department of Health.
Immature sperm cells have been created from stem cells in human bone marrow. The research has potential application for the treatment for male infertility.
deCODE genetics, Inc. (Nasdaq:DCGN) announced the launch of deCODE T2?, a novel DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D).
Eating such foods as broccoli and soy are believed to offer some protection against cancer, but how this occurs is not well-understood.
Mayo Clinic Cancer Center researchers have found that chaetocin, a by-product of a common wood mold, has promise as a new anti-myeloma agent. Results of their study, being presented today at the American Association for Cancer Research annual meeting, show the by-product to be more effective than currently used therapies at killing multiple myeloma cells.
Leukemia, or cancer of the bone marrow, strikes some 700 Belgians each year. Scientists are still searching for the cause of many forms of leukemia, including T-cell acute lymphoblastic leukemia, or T-ALL.